Literature DB >> 27612651

Putting Infection Dynamics at the Heart of Chagas Disease.

Michael D Lewis1, John M Kelly2.   

Abstract

In chronic Trypanosoma cruzi infections, parasite burden is controlled by effective, but nonsterilising immune responses. Infected cells are difficult to detect because they are scarce and focally distributed in multiple sites. However, advances in detection technologies have established a link between parasite persistence and the pathogenesis of Chagas heart disease. Long-term persistence likely involves episodic reinvasion as well as continuous infection, to an extent that varies between tissues. The primary reservoir sites in humans are not definitively known, but analysis of murine models has identified the gastrointestinal tract. Here, we highlight that quantitative, spatial, and temporal aspects of T. cruzi infection are central to a fuller understanding of the association between persistence, pathogenesis, and immunity, and for optimising treatment.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27612651      PMCID: PMC5086431          DOI: 10.1016/j.pt.2016.08.009

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  108 in total

1.  Tissue tropism of different Trypanosoma cruzi strains.

Authors:  R C Melo; Z Brener
Journal:  J Parasitol       Date:  1978-06       Impact factor: 1.276

2.  Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.

Authors:  L Zhang; R L Tarleton
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

Review 3.  Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis.

Authors:  F Köberle
Journal:  Adv Parasitol       Date:  1968       Impact factor: 3.870

4.  Molecular characterization of Trypanosoma cruzi Mexican strains and their behavior in the mouse experimental model.

Authors:  César Gómez-Hernández; Karine Rezende-Oliveira; Gabriel Antônio Nogueira Nascentes; Lara Rocha Batista; Henrique Borges Kappel; José Alejandro Martinez-Ibarra; Francisco Trujillo Contreras; Eliane Lages-Silva; Luis Eduardo Ramírez
Journal:  Rev Soc Bras Med Trop       Date:  2011-11-21       Impact factor: 1.581

5.  Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.

Authors:  A L de Andrade; F Zicker; R M de Oliveira; S Almeida Silva; A Luquetti; L R Travassos; I C Almeida; S S de Andrade; J G de Andrade; C M Martelli
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

6.  Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart disease.

Authors:  Alejandro G Schijman; Carlos A Vigliano; Rodolfo J Viotti; Juan M Burgos; Silvia Brandariz; Bruno E Lococo; Maria I Leze; Hector A Armenti; Mariano J Levin
Journal:  Am J Trop Med Hyg       Date:  2004-02       Impact factor: 2.345

7.  Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN- mice with two clones isolated from a common source.

Authors:  M Postan; J A Dvorak; J P McDaniel
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

8.  The neuromuscular pathology of experimental Chagas' disease.

Authors:  H A Molina; R L Cardoni; M T Rimoldi
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

9.  Molecular identification of Trypanosoma cruzi I tropism for central nervous system in Chagas reactivation due to AIDS.

Authors:  Juan M Burgos; Sandra Begher; Helder M Valadares Silva; Margarita Bisio; Tomas Duffy; Mariano J Levin; Andrea M Macedo; Alejandro G Schijman
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

10.  Development of an aptamer-based concentration method for the detection of Trypanosoma cruzi in blood.

Authors:  Rana Nagarkatti; Vaibhav Bist; Sirena Sun; Fernanda Fortes de Araujo; Hira L Nakhasi; Alain Debrabant
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more
  34 in total

Review 1.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

Review 2.  Chronic Chagas Disease-the Potential Role of Reinfections in Cardiomyopathy Pathogenesis.

Authors:  Christian Olivo Freites; Hendrik Sy; Amal Gharamti; Nelson I Agudelo Higuita; Carlos Franco-Paredes; José Antonio Suárez; Andrés F Henao-Martínez
Journal:  Curr Heart Fail Rep       Date:  2022-08-11

Review 3.  Central role of metabolism in Trypanosoma cruzi tropism and Chagas disease pathogenesis.

Authors:  Zongyuan Liu; Rebecca Ulrich vonBargen; Laura-Isobel McCall
Journal:  Curr Opin Microbiol       Date:  2021-08-26       Impact factor: 7.584

Review 4.  Metabolic flexibility in Trypanosoma cruzi amastigotes: implications for persistence and drug sensitivity.

Authors:  Peter C Dumoulin; Barbara A Burleigh
Journal:  Curr Opin Microbiol       Date:  2021-08-26       Impact factor: 7.584

Review 5.  Paving the Way: Contributions of Big Data to Apicomplexan and Kinetoplastid Research.

Authors:  Robyn S Kent; Emma M Briggs; Beatrice L Colon; Catalina Alvarez; Sara Silva Pereira; Mariana De Niz
Journal:  Front Cell Infect Microbiol       Date:  2022-06-06       Impact factor: 6.073

Review 6.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

7.  Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease.

Authors:  Teresa Vinuesa; Rocio Herráez; Laura Oliver; Elisa Elizondo; Argia Acarregui; Amaia Esquisabel; Jose Luis Pedraz; Nora Ventosa; Jaume Veciana; Miguel Viñas
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

Review 8.  Biological factors that impinge on Chagas disease drug development.

Authors:  Amanda F Francisco; Shiromani Jayawardhana; Michael D Lewis; Martin C Taylor; John M Kelly
Journal:  Parasitology       Date:  2017-08-23       Impact factor: 3.234

Review 9.  Transcriptional Studies on Trypanosoma cruzi - Host Cell Interactions: A Complex Puzzle of Variables.

Authors:  María Gabriela Libisch; Natalia Rego; Carlos Robello
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

10.  Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.

Authors:  Augusto E Bivona; Andrés Sánchez Alberti; Marina N Matos; Natacha Cerny; Alejandro C Cardoso; Celina Morales; Germán González; Silvia I Cazorla; Emilio L Malchiodi
Journal:  PLoS Negl Trop Dis       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.